welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics
study id #: NCT03027401
condition: Neoplasms, Adenomatous Polyposis Coli, Neurofibroma Plexiform, Myelodysplastic Syndromes
status: withdrawn
purpose:Background:
Saliva, blood, tissue, and cancer contain DNA. DNA makes the “instruction book” for the cells in the body. Cancer is caused by changes in DNA that affect cell function. Researchers want to test DNA of people with tumors. They want to look for genetic changes in tumors that could be targets for treatment. Because DNA can change as cancer changes, more testing may be done at different times.
Objectives:
To find the DNA changes in cancer that may help guide treatment. To collect samples and data to be used in future studies.
Eligibility:
People any age with cancer or a pre-cancerous tumor
Design:
• Participants will be screened with a medical history, physical exam, and blood tests. Participants will give a sample of their tumor. This is usually from a previous procedure. Participants will give a saliva or blood sample. They cannot eat, drink, smoke, or chew gum for 30 minutes before giving saliva. They will spit about 1 teaspoon of saliva into a tube.
• Some participants may have a punch biopsy instead. A small instrument will take a small piece of skin.
• Researchers will collect data from participants medical records.
• Participants will answer questions about their family health history. They will also answer questions about their views on the study, including possible unexpected results.
• Extra blood or tissue samples may be taken at other times during the participants’ treatment. All samples will be saved in secure ClinOmics freezers to be used in future studies.
• Participants will be told by their doctors if any test results affect their health or their cancer treatment.
expertly curated content related to this topic
-
Independent Data Monitoring Committee Recommends Continuation of Cancer Prevention Pharmaceuticals’ Phase 3 Trial ...Cancer Prevention Pharmaceuticals, Inc. ...
-
Adenomatous Polyposis Coli Tumour Suppressorhttps://www.youtube.com/watch?v=0vsRwJ6p...
-
Different Phenotype Manifestation of Familial Adenomatous Polyposis in Families with APC Mutation at Codon 1309Germline mutation in APC gene induced de...
-
Colorectal Carcinomas, A Consideration on MutYH-Associated PolyposisColorectal cancer (CRC) is the second mo...
-
Location in the Large Bowel Influences the APC Mutations Observed in FAP AdenomasThe right colon differs from the left, i...
-
MUTYH-Associated Polyposis – Variability of the Clinical Phenotype in Patients with Biallelic and Monoallelic ...To further characterize 215 APC mutation...
-
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal AnastomosesThe primary purpose of this prospective,...